Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)

NCT02269267 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT02269267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02269267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Completed
Start date
December 18, 2014
Completion date
April 6, 2022
Enrollment
173 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myeloid, chronic